News
Cardiogenic shock rate soars in COVID-positive ACS
In-hospital mortality was quadrupled in COVID-positive STEMI patients.
News
VOYAGER PAD: Paclitaxel-coated devices don’t increase mortality
“I think this study is a game changer. And I think the paclitaxel game is over.” – Dr. Frank Veith
News
Melancholic, psychotic depression may protect against ECT cognitive effects
One study found that psychotic depression was associated with a 1.7-fold increased likelihood of response to ECT, reported Dr. Linda van Diermen...
News
Include irritability in ADHD suicidality risk assessments
Interventional studies aimed at dampening irritability as a potential strategy to reduce suicidality should be prioritized, said Dr. Tomer Levy....
News
Strategies offered for optimizing ECT anesthesia
Plus, Dr. Alexander Sartorius describes how to recognize and manage ECT’s chief anesthesia-related side effects.
News
Adjunctive pimavanserin looks promising for anxious depression
It’s estimated that roughly 50% of individuals with major depressive disorder have comorbid anxiety disorders or a high level of anxiety symptoms...
News
MitraClip effective for post-MI acute mitral regurgitation with cardiogenic shock
“The development of cardiogenic shock should not preclude percutaneous mitral valve repair in this scenario.” – Dr. Rodrigo Estevez-Loureiro
News
Intravascular lithotripsy hailed as ‘game changer’ for coronary calcification
Positive results reported from the U.S. pivotal Disrupt CAD III study sets stage for regulatory approval.
Article
Ticagrelor monotherapy beats DAPT in STEMI
One-year results of the randomized TICO-STEMI trial suggests aspirin can be dropped safely after 3 months, but the findings need confirmation,...
News
Repurposing cardiovascular drugs for serious mental illness
What these agents have in common, the investigators observed, is that they act on inflammation and potentially on the stress response system.
News
Benefit of rivaroxaban after limb revascularization greatest in those with comorbid CAD
New results from the landmark VOYAGER PAD trial identify which patients benefit most from adding rivaroxaban after limb revascularization.
News
Teen affective disorders raise risk for midlife acute MI
“Effective prevention might focus on behavior, lifestyle, and psychosocial stress in early life,” said Dr. Cecilia Bergh.
News
Divergent COVID-19 mental health impacts seen in Spain and China
A tale of two pandemic epicenters with vastly different outcomes to date.
News
Listening to Mozart helps tame epilepsy
The data documented a 31% reduction in seizure frequency and 28% decrease in interictal epileptiform discharges during a single listen.
News
Cognitive impairments in major depression cluster in three patterns
The EMOTICOM test battery is a novel neuropsychological test battery developed specifically to assess what has been called “hot” cognition.